Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study 21-04-2023, 03:01

HealthTech Startup Healistic Raises €1M in Funding and 1-02-2023, 15:23

Aqua Sculpt Reviews (BREAKING) Recent Consumer Reports Unveil What You Must Know Before Buying AquaSculpt 23-03-2025, 08:05